US-based medical device company AcuFocus secured $65m in funding last Tuesday, consisting of $40m in equity and a $25m ‘synthetic royalty’ payment from private equity firm Cowen Healthcare Royalty Partners. Cowen led the round, investing a total of $30m.

Also participating in the round were medical technology company Medtronic, eye health company Bausch & Lomb, and venture capital (VC) firms Versant Ventures, the Carlyle Group and Accuitive Medical Ventures.

Prior to the latest round, AcuFocus had raised about $34.5m, with…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?